| CEO: | Andrew James Webb |
| Chief Scientific Officer: | Christopher McConville |
| Independent Non-Executive Director: | Gerald Beaney |
| Non-Executive Chairman: | Nermeen Yunus Varawalla |
| Non-Executive Dir: |
| Address: | Kingston Chambers, PO Box 173, Road Town, Tortola, British Virgin Islands, USA, |
| Phone: | +1 (925) 408 4621 |
| Website: | http://www.crismtherapeutics.com/ |
| Sector: | Investment Firms(LSE) |
| Index: | FTSE AIM All-Share |
| ISIN: | VGG042401262 |
| Currency | UK Pounds |
| Share Price | 10.50p |
| Change Today | 0.000p |
| % Change | 0.00 % |
| 52 Week High | 10.74 |
| 52 Week Low | 10.00 |
| Volume | 4,375 |
| Shares Issued | 51.74m |
| Market Cap | £5.43m |
| Value |
|
|---|
| Value |
|
|---|
| Income | ![]() |
|---|
| Growth | ![]() |
|---|
| Latest | Previous | |
|---|---|---|
| Special | Interim | |
| Ex-Div | 01-Jun-23 | n/a |
| Paid | 14-Jun-23 | n/a |
| Amount | 1.80p | 0.000¢ |
| Time | Volume / Share Price |
| 09:43 | 1,629 @ 10.74p |
| 09:43 | 2,682 @ 10.74p |
| 08:32 | 64 @ 10.00p |
| CEO | Andrew James Webb |
You are here: research